Clarence Patrick Machado Insider Trading $ADVM Adverum Biotechnologies, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Clarence Patrick Machado.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Clarence Patrick Machado. Clarence Patrick Machado is Director in MEDIVATION, INC. ($MDVN) and Sr. Vice President and CFO in MEDIVATION, INC. ($MDVN) and Director in CHIMERIX INC ($CMRX) and Director in SCYNEXIS INC ($SCYX) and Director in ENDOCYTE INC ($ECYT) and Director in INOTEK PHARMACEUTICALS CORP ($ITEK) and 10% Owner in Arbutus Biopharma Corp ($TKMR) and Director in Principia Biopharma Inc. ($PRNB) and Director in Adverum Biotechnologies, Inc. ($ADVM) and Director in Turning Point Therapeutics, Inc. ($TPTX) and 10% Owner in Axovant Sciences Ltd. ($AXON) and Director in Axovant Sciences Ltd. ($AXON) and 10% Owner in Myovant Sciences Ltd. ($MYOV) and Director in Arcus Biosciences, Inc. ($RCUS) and 10% Owner in Urovant Sciences Ltd. ($UROV).

Clarence Patrick Machado in Adverum Biotechnologies, Inc.

Trading Symbol: ADVM
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Clarence Patrick Machado: Director
Holdings: 88,182 shares
Latest Transaction: May 14 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Clarence Patrick Machado in Adverum Biotechnologies, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADVM, TKMR, RCUS, CMRX, ECYT, MDVN, MYOV, PRNB, RCKT, SCYX, AXON, TPTX, UROV

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 14 2021ADVMAdverum Biotechnol ...Machado PatrickDirectorOption ExerciseA3.7012,50046,25012,500
May 14 2021ADVMAdverum Biotechnol ...Machado PatrickDirectorOption ExerciseA3.7040,000148,00040,000
Mar 24 2021ADVMAdverum Biotechnol ...Machado PatrickDirectorBuyP9.9210,00099,19688,18278.2 K to 88.2 K (+12.79 %)
Jan 19 2021ADVMAdverum Biotechnol ...Machado PatrickDirectorBuyP11.5210,000115,17478,18268.2 K to 78.2 K (+14.67 %)
Jun 25 2020ADVMAdverum Biotechnol ...Machado PatrickDirectorOption ExerciseA25.6430,000769,20030,000
Jan 03 2020ADVMAdverum Biotechnol ...Machado PatrickDirectorOption ExerciseA11.5215,000172,80015,000
Jan 03 2020ADVMAdverum Biotechnol ...Machado PatrickDirectorOption ExerciseA11.5215,000172,80015,000
Aug 02 2019ADVMAdverum Biotechnol ...Machado PatrickDirectorOption ExerciseA13.4145,000603,45045,000
Jun 15 2018ADVMAdverum Biotechnol ...Machado PatrickDirectorOption ExerciseA6.2535,000218,75035,000
Feb 20 2018ADVMAdverum Biotechnol ...Machado PatrickDirectorOption ExerciseA6.4010,00064,00010,000
Jun 14 2017ADVMAdverum Biotechnol ...Machado PatrickDirectorOption ExerciseA2.7533,60292,40633,602
Jun 14 2017ADVMAdverum Biotechnol ...Machado PatrickDirectorGrantA0.0022,727068,18245.5 K to 68.2 K (+50.00 %)
Mar 16 2017ADVMAdverum Biotechnol ...Machado PatrickDirectorOption ExerciseA2.7564,767178,10964,767
Mar 16 2017ADVMAdverum Biotechnol ...Machado PatrickDirectorGrantA0.0045,455045,4550 to 45.5 K

Page:   1